Pediatrix Medical (MD) Cash from Investing Activities (2009 - 2026)

Pediatrix Medical (MD) has 18 years of Cash from Investing Activities data on file, last reported at -$12.0 million in Q1 2026.

• Quarterly Cash from Investing Activities fell 60.49% year-over-year to -$12.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$22.8 million (up 14.35% YoY) and the FY2025 annual result came in at -$18.3 million, up 48.33% from the prior year.
• Cash from Investing Activities slipped to -$12.0 million in Q1 2026 per MD's latest filing, from -$10.3 million in the prior quarter.
• Across five years, Cash from Investing Activities topped out at $6.6 million in Q3 2025 and bottomed at -$26.3 million in Q1 2022.
• The 5-year median for Cash from Investing Activities is -$11.2 million (2022), against an average of -$10.0 million.
• Peak annual rise in Cash from Investing Activities reached 252.24% in 2025, while the deepest fall reached 430.55% in 2025.
• Tracing MD's Cash from Investing Activities over 5 years: stood at -$11.2 million in 2022, then slipped by 10.52% to -$12.4 million in 2023, then soared by 84.4% to -$1.9 million in 2024, then sank by 430.55% to -$10.3 million in 2025, then fell by 16.5% to -$12.0 million in 2026.
• Per Business Quant, the three latest MD Cash from Investing Activities figures stand at -$12.0 million (Q1 2026), -$10.3 million (Q4 2025), and $6.6 million (Q3 2025).

Peer Comparison